"Squalene" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A natural 30-carbon triterpene.
Descriptor ID |
D013185
|
MeSH Number(s) |
D02.455.326.271.665.806 D02.455.849.919.681
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Squalene".
Below are MeSH descriptors whose meaning is more specific than "Squalene".
This graph shows the total number of publications written about "Squalene" by people in this website by year, and whether "Squalene" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Squalene" by people in Profiles.
-
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults. Vaccine. 2024 Jan 12; 42(2):295-309.
-
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older. Vaccine. 2021 02 22; 39(8):1339-1348.
-
Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant. Clin Vaccine Immunol. 2016 01; 23(1):73-7.
-
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. JAMA. 2015 Jul 21; 314(3):237-46.
-
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. JAMA. 2014 Oct 08; 312(14):1420-8.